Clinical Trials
3 trialsNCT05982678 2025-11-26
ANISE
The Netherlands Cancer Institute
Phase 2 Recruiting
NCT05710666 2024-08-05
Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)
Cancer Trials Ireland
Phase 2 Active not recruiting
NCT05458401 2024-03-15
EUROPA T-DXd
Daiichi Sankyo
Completed